4//SEC Filing
SUMER JACQUELYN L 4
Accession 0000899243-22-028821
CIK 0001789972other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 5:07 PM ET
Size
5.8 KB
Accession
0000899243-22-028821
Insider Transaction Report
Form 4
SUMER JACQUELYN L
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-08-15+190,000→ 190,000 totalExercise: $14.16Exp: 2032-08-14→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 190,000 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on August 15, 2023, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001844824
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 5:07 PM ET
- Size
- 5.8 KB